Kestra Medical Technologies (KMTS)
Leases connected wearable defibrillator systems for patients at elevated sudden-cardiac-arrest risk.
Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience
KIRKLAND, Wash., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced the appointment of Curtis Kopf as Senior Vice President of Customer Experience. In this newly created role, Mr. Kopf will lead the patient experience from approval of a patient order through completion of therapy and device return, aligning the people, processes and technology that support providers and their patients throughout the use of the ASSURE® WCD.
Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?
Kestra Medical Technologies, Ltd. (KMTS) saw its shares surge in the last session with trading volume being higher than average.
Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript
Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript
Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates
Kestra Medical Technologies, Ltd. (KMTS) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.59.
Kestra Medical Technologies Q4 Earnings Call Highlights
Kestra Medical Technologies NASDAQ: KMTS reported a sharp increase in fourth-quarter revenue and issued fiscal 2027 guidance calling for continued growth, as executives said demand for the company's ASSURE wearable cardioverter defibrillator system is being driven by new accounts, deeper penetration of existing customers and expansion of its commercial team.
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it has entered into a five-year term loan facility with funds managed by Pharmakon Advisors, LP.
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results
KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the fourth quarter and fiscal year ended April 30, 2026.
Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14
KIRKLAND, Wash., June 30, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report fourth quarter fiscal 2026 financial results after the market closes on Tuesday, July 14.
What a $312,000 Kestra Insider Sale Signals After 25% Stock Gains
This cardiac device innovator saw a notable insider sale, as routine portfolio moves continue amid its push in digital health solutions.
Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference
KIRKLAND, Wash., April 29, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
Kestra Showcases Accelerated Innovation at HRS 2026
KIRKLAND, Wash., April 22, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner
KIRKLAND, Wash., April 09, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
The Kestra Director Who Built and Sold a Device Company Keeps Buying Stock
Director Raymond W. Cohen acquired 10,000 shares for a transaction value of approximately $200,000 on March 26, 2026.
Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”
KIRKLAND, Wash., March 25, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced it has been named a finalist in the “Deal of the Year” category for the 2026 GeekWire Awards. Now in its 15th year, the annual awards recognize companies and leaders shaping the Pacific Northwest technology ecosystem, where Kestra continues to expand its presence.
Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells $304,050.00 in Stock
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS - Get Free Report) insider Brian Daniel Webster sold 15,000 shares of the company's stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $20.27, for a total transaction of $304,050.00. Following the sale, the insider directly owned 364,786 shares of
Kestra Medical Technologies, Ltd. (KMTS) Q3 2026 Earnings Call Transcript
Kestra Medical Technologies, Ltd. (KMTS) Q3 2026 Earnings Call Transcript
Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results
KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the third quarter fiscal 2026, which ended January 31, 2026.
Kestra Medical Technologies to Report Third Quarter Fiscal 2026 Financial Results on March 17
KIRKLAND, Wash., March 03, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it will report third quarter fiscal 2026 financial results on Tuesday, March 17. Management will host a corresponding conference call at 4:30 p.m. Eastern Time.
Kestra Medical Technologies (NASDAQ:KMTS) Insider Brian Daniel Webster Sells 15,000 Shares
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS - Get Free Report) insider Brian Daniel Webster sold 15,000 shares of the firm's stock in a transaction dated Thursday, January 15th. The shares were sold at an average price of $22.80, for a total value of $342,000.00. Following the sale, the insider owned 394,786 shares in the company, valued
Short Interest in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Rises By 21.5%
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS - Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 2,413,847 shares, an increase of 21.5% from the December 15th total of 1,986,266 shares. Currently, 4.3% of the shares of the company